← Leaderboards
Daniel Arthur Rauch
Washington University
$1,325,070
Attributed
$2,650,140
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,650,140 · 4
By mechanism
R01$1,415,907 · 1
R21$1,234,233 · 3
Top collaborators
- Lee Ratner10 shared
Most similar at Washington University
Same institution · by research overlap
- Lee Ratner$26,026,037
- Vera L. Tarakanova$6,716,721
- Delphine L Chen$4,481,188
- Roberta Faccio$8,150,057
- Vaishali Kapoor$459,633
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsCell LineT-LymphocyteMolecularMalignant NeoplasmsRefractoryTranscriptome SequencingGenesVirusIrf4 GeneViral OncogeneTumorigenesisAdult T-Cell Leukemia/LymphomaAnimal ModelHuman T-Lymphotropic Virus 1Gene ProductGene TargetingMutateMutationGene ExpressionApoptosisMediatingInhibitorClinic
Grant awards (10)
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$360,282
R01 · FY2025 · CA
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$342,267
R01 · FY2024 · CA
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$353,076
R01 · FY2023 · CA
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma$360,282
R01 · FY2022 · CA
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma$236,250
R21 · FY2022 · CA
Interaction of HTLV-1 Tax & Hbz in Transformation$216,476
R21 · FY2022 · CA
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia$216,476
R21 · FY2022 · CA
Single-Cell Transcriptome & Effect of Immune Checkpoint Therapy on Kaposi Sarcoma$196,875
R21 · FY2021 · CA
Role of Protein Kinase C Mutations in Adult T-Cell Leukemia$184,078
R21 · FY2021 · CA
Interaction of HTLV-1 Tax & Hbz in Transformation$184,078
R21 · FY2021 · CA